Xin heads the China office of GPC. Previously, Xin was the head of business development Asia Pacific for GlaxoSmithKline, where she was responsible for business development strategies and opportunities within China, India and other Asian countries. She has originated and executed a number of strategic acquisitions, including the first landmark 100% takeover of a Chinese pharmaceutical group by a foreign multi-national. Prior to that her experience includes leadership positions in corporate M&A, licensing and divestments, strategic planning, marketing and sales with Hoffmann-la Roche, Eli Lilly and Merck KGaA. She holds a Master degree in Molecular Biology with additional qualification in Business Administration from the University of Cologne, Germany, where she won scholarship from Friedrich-Naumann-Foundation for her study.